March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Cone Photoreceptor Structure in Achromatopsia
Author Affiliations & Notes
  • Venki Sundaram
    Ophthalmology, Div of Molecular Therapy,
    Institute of Ophthalmology, London, United Kingdom
  • Caroline Wilde
    Ophthalmology, Div of Molecular Therapy,
    Institute of Ophthalmology, London, United Kingdom
  • Andrew R. Webster
    Molecular Genetics,
    Institute of Ophthalmology, London, United Kingdom
  • Anthony T. Moore
    Ophthalmology, Div of Molecular Therapy,
    Institute of Ophthalmology, London, United Kingdom
  • Marko Nardini
    Ophthalmology, Div of Molecular Therapy,
    Institute of Ophthalmology, London, United Kingdom
  • Robin R. Ali
    Ophthalmology, Div of Molecular Therapy,
    UCL Institute of Ophthalmology, London, United Kingdom
  • James W. Bainbridge
    UCL Institute of Ophthalmology, London, United Kingdom
  • Joseph Carroll
    Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • Michel Michaelides
    Medical Retina Department, Moorfields Eye Hospital, London, United Kingdom
  • Footnotes
    Commercial Relationships  Venki Sundaram, None; Caroline Wilde, None; Andrew R. Webster, None; Anthony T. Moore, None; Marko Nardini, None; Robin R. Ali, None; James W. Bainbridge, None; Joseph Carroll, None; Michel Michaelides, None
  • Footnotes
    Support  Foundation Fighting Blindness (FFB; Owings Mills, MD, USA), Moorfields Special Trustees, Fight for Sight, NIHR to BRC at Moorfields, UCL Institute of Ophthalmology
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2678. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Venki Sundaram, Caroline Wilde, Andrew R. Webster, Anthony T. Moore, Marko Nardini, Robin R. Ali, James W. Bainbridge, Joseph Carroll, Michel Michaelides; Cone Photoreceptor Structure in Achromatopsia. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2678.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Achromatopsia (ACHM) is considered to be a stationary cone disorder with animal studies suggesting it may be a good candidate for gene replacement therapy. Recent clinical studies have suggested that progressive cone loss may occur with age. This study further investigates the integrity of cone photoreceptors in ACHM.

Methods: : 60 eyes of 30 patients with ACHM underwent spectral domain optical coherence tomography (SDOCT) imaging (49 B-scans, 20°x20°, 12 frames per B-scan). SDOCT retinal appearance was classified as (1) normal outer retinal structure, (2) inner segment/outer segment disruption, (3) hyporeflective zone presence and (4) complete cone and RPE cell layer disruption.

Results: : Mean age of subjects was 26.3 years (range 8-53 years). 20% of eyes had normal outer retinal structure, 30% had inner segment/outer segment disruption, 37 % had a hyporeflective zone present, and 13 % had complete cone and RPE cell layer disruption. There was high inter-eye correlation of SDOCT changes. There was no significant difference in age of subjects (p=0.760) or visual acuity (p=0.152) between the SDOCT change categories.

Conclusions: : SDOCT changes in ACHM can vary from apparently normal outer retinal structure to complete cone loss with RPE involvement. These changes were not present in an age-dependent manner, or associated with visual acuity; implying that the window of opportunity for gene therapy intervention may extend into adulthood, and prospective patients need to be assessed on an individual basis, irrespective of age.

Keywords: gene transfer/gene therapy • photoreceptors • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×